Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
MARLBOROUGH, Mass.--(BUSINESS WIRE)--Advanced Cell Technology, Inc. (“ACT”; OTCQB: ACTC), a leader in the field of regenerative medicine, announced that it has filed preliminary proxy materials with the Securities and Exchange Commission (SEC) in connection with its 2013 Annual Meeting of Stockholders on October 22, 2013 (the “2013 Annual Meeting”). The proposals at the 2013 Annual Meeting include: Election of the six director nominees listed in the proxy statement
Help employers find you! Check out all the jobs and post your resume.
MARLBOROUGH, Mass.--(BUSINESS WIRE)--Advanced Cell Technology, Inc. (“ACT”; OTCQB: ACTC), a leader in the field of regenerative medicine, announced that it has filed preliminary proxy materials with the Securities and Exchange Commission (SEC) in connection with its 2013 Annual Meeting of Stockholders on October 22, 2013 (the “2013 Annual Meeting”). The proposals at the 2013 Annual Meeting include: Election of the six director nominees listed in the proxy statement
Help employers find you! Check out all the jobs and post your resume.
